Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The debate over immediate lymph node dissection in melanoma.

H S Goldsmith

    Surgery, Gynecology & Obstetrics
    |March 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial: Omental transposition for cerebral revascularization.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
    Same author

    Angiogenic capacity of human omental stem cells.

    Neurological research·2005
    Same author

    Fecal control following pyloric valve transposition after abdominoperineal resection.

    Techniques in coloproctology·2003
    Same author

    Role of the omentum in the treatment of Alzheimer's disease.

    Neurological research·2001
    Same author

    Omental transposition for cerebral infarction: a 13-year follow-up study.

    Surgical neurology·1999
    Same author

    Acute spinal cord injuries: a search for functional improvement.

    Surgical neurology·1999

    Advanced melanoma patients require timely treatment of regional lymph nodes, rejecting a "wait and see" approach. Critical evaluation of biologic determinism in lymph node management is essential for optimal patient outcomes.

    Area of Science:

    • Oncology
    • Dermatology
    • Surgical Oncology

    Background:

    • Advanced primary melanoma, particularly thick level 5 nodular lesions, presents a significant clinical challenge.
    • The management of regional lymph nodes in such cases remains a critical aspect of treatment planning.
    • Current treatment philosophies, including expectant management, warrant careful consideration.

    Purpose of the Study:

    • To advocate for proactive treatment of regional lymph nodes in advanced melanoma.
    • To question the validity of a
    • wait and see
    • approach for affected lymph nodes.
    • To encourage critical re-evaluation of the concept of biologic determinism in melanoma lymph node metastasis.

    Main Methods:

    Related Experiment Videos

  • This is a perspective piece based on clinical experience and interpretation of existing data.
  • It involves a critical analysis of the current understanding of melanoma progression and lymph node involvement.
  • No new clinical trials or patient data were generated for this specific commentary.

    • Main Results:

    • The World Health Organization report did not alter the author's conviction regarding the necessity of treating regional lymph nodes.
    • The method of treatment (excision vs. perfusion) is considered secondary to the principle of active management.
    • The primary outcome is a call for critical appraisal of established concepts.

    Conclusions:

    • A
    • wait and see
    • philosophy for regional lymph nodes in advanced melanoma is not in the patient's best interest.
    • Active management of regional lymph nodes is crucial, regardless of the specific treatment modality.
    • Clinicians globally should critically examine the concept of biologic determinism in advanced melanoma lymph node management.